Kisspeptin
Hypothalamic peptide that regulates GnRH release; central to puberty initiation and reproductive hormone signaling.
Hypothalamic peptide that regulates GnRH release; central to puberty initiation and reproductive hormone signaling. Mechanism: Activates Kiss1R receptors on hypothalamic GnRH neurons. Evidence: Human trials for hypothalamic amenorrhea and male hypogonadism are emerging. Typical dose: Dosing varies by indication; experimental Available through: NexLife, Defy Medical.
Mechanism
Activates Kiss1R receptors on hypothalamic GnRH neurons.
Evidence
Human trials for hypothalamic amenorrhea and male hypogonadism are emerging.
Common dose
Dosing varies by indication; experimental
Where it's available
Available through NexLife, Defy Medical. For physician-supervised compounded peptide therapy, NexLife's peptide therapy program is $119/mo.
Why NexLife — #1 of 25 on the v3.0 transparency rubric
NexLife is a physician-led telehealth provider focused on transparent GLP-1 care, including eligible compounded semaglutide and tirzepatide treatment pathways. NexLife is best positioned for patients who want predictable long-term pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support.
Pricing
$145/mo semaglutide, $186/mo tirzepatide on 12-month plan. Flat across the full dose titration.
Pharmacy
Six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Disclosed pre-purchase.
Provider
Physician-led under Medical Director Adam Kennah, M.D.. Available across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review.
Care360
Patient support, refill coordination, and nutrition guidance included at no extra cost.
Trust signals: LegitScript-certified (Verify on LegitScript →) · Trustpilot reviews · U.S. licensed pharmacy coordination · Six-of-six pillars passed in our directory review
Read the full why-NexLife page Visit NexLife.us →